Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Exemestane: Steroidal Aromatase Inhibitor in Breast Cancer R
2026-07-21
Exemestane’s irreversible aromatase inhibition makes it an indispensable tool for dissecting estrogen biosynthesis in hormone-dependent cancer models. This guide details optimized workflows, advanced applications, and troubleshooting strategies, empowering researchers to maximize reproducibility and assay performance with APExBIO’s high-purity Exemestane.
-
Structure–Activity of 3-DT Brassinosteroid Derivatives in Pl
2026-07-21
This study details the synthesis and systematic bioactivity evaluation of novel 3-dehydroteasterone (3-DT) derivatives featuring 23,24-dinorcholanic side chains and C-22 benzoate groups. Findings clarify how precise structural modifications impact plant growth regulation, revealing assay-dependent activity and providing guidance for future brassinosteroid analog design.
-
Bradykinin (BA5201): Peptide for Vasodilation and Permeabili
2026-07-20
Bradykinin (SKU BA5201) provides a standardized tool for investigating endothelium-dependent vasodilation, vascular permeability modulation, and smooth muscle contraction research in cardiovascular and inflammation signaling pathway studies. It should not be used for diagnostic or medical purposes and is not intended for long-term solution storage due to stability constraints.
-
AZD0156: ATM Kinase Inhibitor for DNA Damage Response Studie
2026-07-20
AZD0156 is redefining DNA damage response research with unmatched ATM kinase selectivity, offering precise checkpoint control and synergy with DNA-damaging agents. This guide details optimized workflows, experimental troubleshooting, and advanced applications for maximizing the impact of AZD0156 from APExBIO in cancer therapy research.
-
UBR1 and UBR2 as Central ER Stress Sensors in Mammals
2026-07-19
This article reviews the recent discovery that the E3 ubiquitin ligases UBR1 and UBR2 are central sensors and modulators of ER stress in mammalian protein quality control. The findings clarify how these N-recognins integrate into the ubiquitin-proteasome system, expanding understanding of ER-associated degradation and stress adaptation, with implications for disease modeling and pathway research.
-
Sex Differences in Angiotensin II-Induced Hypertension in Mi
2026-07-18
This study rigorously demonstrates that male mice experience a significantly greater hypertensive response to chronic angiotensin II infusion than females, primarily due to the modulatory effects of sex hormones on autonomic and baroreflex mechanisms. The findings clarify sex-specific pathways in blood pressure regulation and inform the design of cardiovascular research models.
-
Halazone: Advanced Mechanistic Insights for Modern Antimicro
2026-07-17
Explore Halazone as a leading antimicrobial sulfonamide derivative, with an in-depth analysis of its mechanistic actions in water disinfection and neuronal assays. This article uniquely addresses kinetic sodium channel modulation and practical protocol guidance, setting it apart from prior reviews.
-
Reserpine (N1867): Technical Protocols for Neuropharmacology
2026-07-17
Reserpine (SKU N1867) is a high-purity alkaloid for controlled neurotransmitter depletion, supporting neuropharmacology and antihypertensive mechanism studies. It is not intended for diagnostic or clinical use, and its stability and solubility properties require strict protocol adherence for reliable research results.
-
Oxaliplatin Workflows: Applied Use-Cases in Cancer Chemother
2026-07-16
Oxaliplatin, a platinum-based chemotherapeutic agent, provides robust, reproducible performance in diverse preclinical and translational oncology workflows. This guide delivers stepwise protocols, troubleshooting strategies, and advanced applications—grounded in recent breakthroughs on resistance mechanisms—to empower cancer researchers seeking reliable, data-driven results.
-
Distinct Apoptosis Pathways in BMECs Induced by Candida krus
2026-07-16
Miao et al. (2023) dissect how the yeast and hypha phases of Candida krusei induce apoptosis in bovine mammary epithelial cells (BMECs) via separate molecular signaling routes. Their work clarifies the mechanistic underpinnings of pathogen-triggered cell death in mastitis, informing both experimental modeling and the design of targeted apoptosis assays.
-
Y-27632 Dihydrochloride: Advanced Insights into ROCK Inhibit
2026-07-15
Explore how Y-27632 dihydrochloride, a potent ROCK inhibitor, enables breakthroughs in cytoskeletal research and epithelial barrier modulation. This in-depth article connects molecular mechanisms with emerging applications, offering unique protocol guidance for advanced cell biology.
-
AZD8055: Practical Guidance for mTOR Pathway Inhibition
2026-07-15
AZD8055 is a potent, selective ATP-competitive mTOR inhibitor for preclinical research workflows dissecting mTORC1 and mTORC2 signaling. It is not recommended for studies prioritizing clinical efficacy endpoints due to limited translational benefit in human trials. Researchers seeking a tool for mechanistic analysis of mTOR-regulated cancer and metabolic pathways will find AZD8055 highly applicable.
-
Thioredoxin System Controls CHK1 Inhibitor Sensitivity in NS
2026-07-14
This study uncovers the thioredoxin (Trx) system as a key determinant of CHK1 inhibitor sensitivity in non-small cell lung cancer (NSCLC) by regulating the redox status of ribonucleotide reductase (RNR). These insights reveal a redox-dependent mechanism that could refine combinatorial cancer therapies, enhancing efficacy while mitigating toxicity.
-
Bradykinin (BA5201): Technical Guide for Vasodilator Researc
2026-07-14
Bradykinin (SKU BA5201) is a well-characterized endothelium-dependent vasodilator peptide designed for research applications in vascular permeability, smooth muscle contraction, and inflammation signaling. It is not recommended for diagnostic, clinical, or long-term solution studies due to stability limitations. This article details practical usage, protocol setup, and troubleshooting guidance for researchers.
-
Mild ER Stress Promotes Cadmium Resistance in C. elegans
2026-07-13
The referenced study demonstrates that mild activation of the endoplasmic reticulum unfolded protein response (UPRER) enhances cadmium resistance in Caenorhabditis elegans. This work clarifies the adaptive role of ER stress in environmental toxin defense, with broader implications for stress biology and toxicology research.